<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101120023</journal-id>
<journal-id journal-id-type="pubmed-jr-id">30092</journal-id>
<journal-id journal-id-type="nlm-ta">World J Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">World J. Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1562-2975</issn>
<issn pub-type="epub">1814-1412</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27170266</article-id>
<article-id pub-id-type="pmc">5435559</article-id>
<article-id pub-id-type="doi">10.3109/15622975.2016.1173724</article-id>
<article-id pub-id-type="manuscript">NIHMS854753</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Testing Differential Susceptibility: Plasticity Genes, the Social Environment, and Their Interplay in Adolescent Response Inhibition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Richards</surname>
<given-names>Jennifer S.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vásquez</surname>
<given-names>Alejandro Arias</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Rooij</surname>
<given-names>Daan</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van der Meer</surname>
<given-names>Dennis</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franke</surname>
<given-names>Barbara</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoekstra</surname>
<given-names>Pieter J.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heslenfeld</surname>
<given-names>Dirk J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oosterlaan</surname>
<given-names>Jaap</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faraone</surname>
<given-names>Stephen V.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hartman</surname>
<given-names>Catharina A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buitelaar</surname>
<given-names>Jan K.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands</aff>
<aff id="A2"><label>2</label>Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands</aff>
<aff id="A3"><label>3</label>Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands</aff>
<aff id="A4"><label>4</label>Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud university medical center, Nijmegen, The Netherlands</aff>
<aff id="A5"><label>5</label>University of Groningen, University Medical Center Groningen, Department of Psychiatry, The Netherlands</aff>
<aff id="A6"><label>6</label>Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, The Netherlands</aff>
<aff id="A7"><label>7</label>SUNY Upstate Medical University Center, Departments of Psychiatry and of Neuroscience and Physiology, Syracuse, USA and the K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Bergen, Norway</aff>
<author-notes>
<corresp id="FN1">Corresponding author: Jennifer S. Richards, Radboud university medical center, Department of Cognitive Neuroscience /Karakter Child and Adolescent Psychiatry University Centre, Reinier Postlaan 12, 6525 GC Nijmegen, The Netherlands, <email>Jennifer.Richards@radboudumc.nl</email></corresp>
<fn id="FN2">
<label>#</label>
<p>shared last authorship</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p><bold>Statements of Interest:</bold> In the past year, Dr. Faraone received income, travel expenses and/or research support from and/or has been on an Advisory Board for Pfizer, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA Pharma, Neurovance, Impax, NeuroLifeSciences and research support from the National Institutes of Health (NIH). His institution is seeking a patent for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, he received consulting fees or was on Advisory Boards or participated in continuing medical education programs sponsored by: Shire, Alcobra, Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. Dr. Faraone receives royalties from books published by Guilford Press: <italic>Straight Talk about Your Child's Mental Health</italic> and Oxford University Press: <italic>Schizophrenia: The Facts</italic>. In the past 3 years, Dr. Buitelaar has been a consultant to / member of advisory board of / and/or speaker for Janssen Cilag BV, Eli Lilly, Bristol-Myer Squibb, Shering Plough, UCB, Shire, Novartis and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties. In the past 3 years, Dr. Hoekstra has been a consultant to/member of advisory board of Eli Lilly and Shire. Dr. Oosterlaan has received an unrestricted investigator initiated research grant from Shire. Dr. Franke received a speaker fee from Merck. Ms. Richards, Mr. van Rooij, Mr. van der Meer, and Drs. Heslenfeld, Arias Vásquez and Hartman have no conflicts of interest do declare.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>12</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>18</volume>
<issue>4</issue>
<fpage>308</fpage>
<lpage>321</lpage>
<!--elocation-id from pubmed: 10.3109/15622975.2016.1173724-->
<abstract>
<sec id="S1">
<title>Objectives</title>
<p id="P1">Impaired inhibitory control is a key feature of Attention-Deficit/Hyperactivity Disorder (ADHD). We investigated GxE as a possible contributing factor to response inhibition variation in context of the differential susceptibility theory. This states individuals carrying plasticity gene variants will be more disadvantaged in negative, but more advantaged in positive environments.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Behavioral and neural measures of response inhibition were assessed during a Stop-Signal task in participants with (N=197) and without (N=295) ADHD, from N=278 families (age M=17.18, SD=3.65). We examined GxE between candidate plasticity genes (<italic>DAT1, 5-HTT, DRD4</italic>) and social environments (maternal expressed emotion, peer affiliation).</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">A <italic>DRD4</italic> x Positive peer affiliation interaction was found on the right fusiform gyrus (rFG) activation during successful inhibition. Further, <italic>5-HTT</italic> short allele carriers showed increased rFG activation during failed inhibitions. Maternal warmth and positive peer affiliation were positively associated with right inferior frontal cortex activation during successful inhibition. Deviant peer affiliation was positively related to the error rate.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">While a pattern of differential genetic susceptibility was found, more clarity on the role of the FG during response inhibition is warranted before firm conclusions can be made. Positive and negative social environments were related to inhibitory control. This extends previous research emphasizing adverse environments.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ADHD</kwd>
<kwd>response inhibition</kwd>
<kwd>gene-environment interaction</kwd>
<kwd>social environment</kwd>
<kwd>fMRI</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>